nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C19—urine—polycystic ovary syndrome	0.0246	0.138	CbGeAlD
Levomilnacipran—Contusion—Metformin—polycystic ovary syndrome	0.017	0.0465	CcSEcCtD
Levomilnacipran—Chest discomfort—Metformin—polycystic ovary syndrome	0.0168	0.0459	CcSEcCtD
Levomilnacipran—CYP3A4—urine—polycystic ovary syndrome	0.0145	0.0814	CbGeAlD
Levomilnacipran—CYP2D6—urine—polycystic ovary syndrome	0.0143	0.0801	CbGeAlD
Levomilnacipran—CYP2J2—endometrium—polycystic ovary syndrome	0.013	0.0729	CbGeAlD
Levomilnacipran—CYP2J2—uterus—polycystic ovary syndrome	0.012	0.0672	CbGeAlD
Levomilnacipran—CYP2J2—pituitary gland—polycystic ovary syndrome	0.0118	0.066	CbGeAlD
Levomilnacipran—Migraine—Metformin—polycystic ovary syndrome	0.0106	0.029	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00996	0.0272	CcSEcCtD
Levomilnacipran—Breast disorder—Metformin—polycystic ovary syndrome	0.00975	0.0266	CcSEcCtD
Levomilnacipran—CYP2J2—vagina—polycystic ovary syndrome	0.00975	0.0546	CbGeAlD
Levomilnacipran—Abdominal distension—Metformin—polycystic ovary syndrome	0.00939	0.0256	CcSEcCtD
Levomilnacipran—CYP2J2—endocrine gland—polycystic ovary syndrome	0.00912	0.0511	CbGeAlD
Levomilnacipran—Angina pectoris—Metformin—polycystic ovary syndrome	0.00909	0.0248	CcSEcCtD
Levomilnacipran—Neutropenia—Metformin—polycystic ovary syndrome	0.00872	0.0238	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00867	0.0237	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00787	0.0215	CcSEcCtD
Levomilnacipran—Hepatitis—Metformin—polycystic ovary syndrome	0.00747	0.0204	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00743	0.0203	CcSEcCtD
Levomilnacipran—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00736	0.0201	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00734	0.02	CcSEcCtD
Levomilnacipran—Eye disorder—Metformin—polycystic ovary syndrome	0.00698	0.0191	CcSEcCtD
Levomilnacipran—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00693	0.0189	CcSEcCtD
Levomilnacipran—Flushing—Metformin—polycystic ovary syndrome	0.00693	0.0189	CcSEcCtD
Levomilnacipran—Angiopathy—Metformin—polycystic ovary syndrome	0.00677	0.0185	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00673	0.0184	CcSEcCtD
Levomilnacipran—Chills—Metformin—polycystic ovary syndrome	0.0067	0.0183	CcSEcCtD
Levomilnacipran—Malnutrition—Metformin—polycystic ovary syndrome	0.0065	0.0177	CcSEcCtD
Levomilnacipran—Flatulence—Metformin—polycystic ovary syndrome	0.0064	0.0175	CcSEcCtD
Levomilnacipran—Dysgeusia—Metformin—polycystic ovary syndrome	0.00637	0.0174	CcSEcCtD
Levomilnacipran—Vision blurred—Metformin—polycystic ovary syndrome	0.00613	0.0167	CcSEcCtD
Levomilnacipran—Tremor—Metformin—polycystic ovary syndrome	0.00609	0.0166	CcSEcCtD
Levomilnacipran—Syncope—Metformin—polycystic ovary syndrome	0.00583	0.0159	CcSEcCtD
Levomilnacipran—Palpitations—Metformin—polycystic ovary syndrome	0.00574	0.0157	CcSEcCtD
Levomilnacipran—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00571	0.0156	CcSEcCtD
Levomilnacipran—Hypertension—Metformin—polycystic ovary syndrome	0.00561	0.0153	CcSEcCtD
Levomilnacipran—Chest pain—Metformin—polycystic ovary syndrome	0.00553	0.0151	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0055	0.015	CcSEcCtD
Levomilnacipran—Infection—Metformin—polycystic ovary syndrome	0.00527	0.0144	CcSEcCtD
Levomilnacipran—Shock—Metformin—polycystic ovary syndrome	0.00522	0.0142	CcSEcCtD
Levomilnacipran—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0052	0.0142	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00519	0.0142	CcSEcCtD
Levomilnacipran—Skin disorder—Metformin—polycystic ovary syndrome	0.00515	0.0141	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00513	0.014	CcSEcCtD
Levomilnacipran—CYP2C8—endometrium—polycystic ovary syndrome	0.00507	0.0284	CbGeAlD
Levomilnacipran—Anorexia—Metformin—polycystic ovary syndrome	0.00506	0.0138	CcSEcCtD
Levomilnacipran—SLC6A2—adrenal gland—polycystic ovary syndrome	0.00499	0.028	CbGeAlD
Levomilnacipran—Hypotension—Metformin—polycystic ovary syndrome	0.00496	0.0135	CcSEcCtD
Levomilnacipran—SLC6A4—endocrine gland—polycystic ovary syndrome	0.00492	0.0275	CbGeAlD
Levomilnacipran—Paraesthesia—Metformin—polycystic ovary syndrome	0.00476	0.013	CcSEcCtD
Levomilnacipran—Dyspnoea—Metformin—polycystic ovary syndrome	0.00473	0.0129	CcSEcCtD
Levomilnacipran—Somnolence—Metformin—polycystic ovary syndrome	0.00472	0.0129	CcSEcCtD
Levomilnacipran—Dyspepsia—Metformin—polycystic ovary syndrome	0.00467	0.0127	CcSEcCtD
Levomilnacipran—Decreased appetite—Metformin—polycystic ovary syndrome	0.00461	0.0126	CcSEcCtD
Levomilnacipran—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00459	0.0257	CbGeAlD
Levomilnacipran—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00458	0.0125	CcSEcCtD
Levomilnacipran—Fatigue—Metformin—polycystic ovary syndrome	0.00457	0.0125	CcSEcCtD
Levomilnacipran—Constipation—Metformin—polycystic ovary syndrome	0.00454	0.0124	CcSEcCtD
Levomilnacipran—CYP2C19—vagina—polycystic ovary syndrome	0.00436	0.0244	CbGeAlD
Levomilnacipran—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00434	0.0118	CcSEcCtD
Levomilnacipran—SLC6A2—endocrine gland—polycystic ovary syndrome	0.00433	0.0243	CbGeAlD
Levomilnacipran—Urticaria—Metformin—polycystic ovary syndrome	0.00421	0.0115	CcSEcCtD
Levomilnacipran—Abdominal pain—Metformin—polycystic ovary syndrome	0.00419	0.0114	CcSEcCtD
Levomilnacipran—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00408	0.0228	CbGeAlD
Levomilnacipran—Asthenia—Metformin—polycystic ovary syndrome	0.00381	0.0104	CcSEcCtD
Levomilnacipran—CYP2C8—vagina—polycystic ovary syndrome	0.0038	0.0213	CbGeAlD
Levomilnacipran—Pruritus—Metformin—polycystic ovary syndrome	0.00375	0.0102	CcSEcCtD
Levomilnacipran—Diarrhoea—Metformin—polycystic ovary syndrome	0.00363	0.00991	CcSEcCtD
Levomilnacipran—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00356	0.0199	CbGeAlD
Levomilnacipran—Dizziness—Metformin—polycystic ovary syndrome	0.00351	0.00958	CcSEcCtD
Levomilnacipran—Vomiting—Metformin—polycystic ovary syndrome	0.00337	0.00921	CcSEcCtD
Levomilnacipran—Rash—Metformin—polycystic ovary syndrome	0.00334	0.00913	CcSEcCtD
Levomilnacipran—Dermatitis—Metformin—polycystic ovary syndrome	0.00334	0.00912	CcSEcCtD
Levomilnacipran—ABCB1—embryo—polycystic ovary syndrome	0.00332	0.0186	CbGeAlD
Levomilnacipran—Headache—Metformin—polycystic ovary syndrome	0.00332	0.00907	CcSEcCtD
Levomilnacipran—Nausea—Metformin—polycystic ovary syndrome	0.00315	0.0086	CcSEcCtD
Levomilnacipran—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00272	0.0153	CbGeAlD
Levomilnacipran—CYP2D6—female gonad—polycystic ovary syndrome	0.00255	0.0143	CbGeAlD
Levomilnacipran—ABCB1—endometrium—polycystic ovary syndrome	0.00243	0.0136	CbGeAlD
Levomilnacipran—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00241	0.0135	CbGeAlD
Levomilnacipran—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00237	0.0133	CbGeAlD
Levomilnacipran—ABCB1—uterus—polycystic ovary syndrome	0.00224	0.0126	CbGeAlD
Levomilnacipran—ABCB1—pituitary gland—polycystic ovary syndrome	0.0022	0.0123	CbGeAlD
Levomilnacipran—ABCB1—adipose tissue—polycystic ovary syndrome	0.00219	0.0123	CbGeAlD
Levomilnacipran—ABCB1—adrenal gland—polycystic ovary syndrome	0.00197	0.011	CbGeAlD
Levomilnacipran—ABCB1—female gonad—polycystic ovary syndrome	0.00183	0.0103	CbGeAlD
Levomilnacipran—ABCB1—vagina—polycystic ovary syndrome	0.00182	0.0102	CbGeAlD
Levomilnacipran—ABCB1—endocrine gland—polycystic ovary syndrome	0.00171	0.00955	CbGeAlD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000445	0.000977	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000442	0.000971	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000441	0.000968	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000439	0.000964	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000434	0.000953	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000429	0.000942	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000424	0.00093	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000419	0.00092	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000418	0.000918	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000417	0.000917	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000414	0.000909	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000411	0.000902	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000409	0.000898	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000399	0.000876	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000391	0.000859	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00039	0.000856	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000387	0.000851	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000386	0.000849	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000385	0.000847	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000384	0.000844	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000382	0.00084	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000377	0.000829	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00037	0.000812	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000369	0.000812	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000365	0.000801	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000355	0.000781	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—TH—polycystic ovary syndrome	0.000355	0.000781	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000352	0.000773	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000346	0.000761	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000346	0.00076	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000341	0.00075	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000341	0.00075	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000337	0.00074	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	0.000336	0.000739	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000336	0.000738	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000325	0.000714	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000322	0.000708	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000322	0.000707	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000321	0.000705	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000317	0.000697	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000315	0.000692	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000314	0.00069	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000314	0.00069	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000314	0.000689	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00031	0.00068	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000308	0.000677	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	0.000308	0.000676	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	0.000308	0.000676	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000306	0.000672	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000304	0.000667	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.0003	0.00066	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000293	0.000644	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000291	0.000639	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GNAS—polycystic ovary syndrome	0.00029	0.000637	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000288	0.000633	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000286	0.000629	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	0.000286	0.000628	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	0.000285	0.000626	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00028	0.000615	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00028	0.000614	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NCOR1—polycystic ovary syndrome	0.000276	0.000607	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000276	0.000607	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000275	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000275	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000271	0.000596	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000268	0.000589	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000268	0.000589	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000262	0.000576	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000261	0.000573	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000255	0.000561	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000255	0.00056	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000255	0.000559	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000253	0.000555	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000253	0.000555	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000252	0.000553	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000251	0.000552	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00025	0.000548	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000249	0.000548	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000248	0.000544	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MTHFR—polycystic ovary syndrome	0.000244	0.000537	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.000243	0.000534	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.000243	0.000534	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000235	0.000516	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000234	0.000514	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000234	0.000514	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000233	0.000512	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00023	0.000506	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000221	0.000486	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00022	0.000483	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000217	0.000477	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000217	0.000477	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000212	0.000466	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000212	0.000466	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000209	0.000459	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000206	0.000451	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000205	0.000451	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000204	0.000448	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000202	0.000445	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.0002	0.000439	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.0002	0.000439	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—polycystic ovary syndrome	0.000198	0.000435	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—polycystic ovary syndrome	0.000195	0.000429	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—INS—polycystic ovary syndrome	0.000194	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000193	0.000425	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000192	0.000421	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000189	0.000415	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000184	0.000405	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000182	0.0004	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000182	0.0004	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000181	0.000397	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000178	0.00039	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000176	0.000386	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000172	0.000379	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000168	0.00037	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000167	0.000368	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000165	0.000363	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000165	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000165	0.000361	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000164	0.000361	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000163	0.000357	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000161	0.000353	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000161	0.000353	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000159	0.000349	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000157	0.000344	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000155	0.00034	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000154	0.000337	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000153	0.000336	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000151	0.000332	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000147	0.000323	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000147	0.000322	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000144	0.000315	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000143	0.000314	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000143	0.000314	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.00014	0.000307	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.00014	0.000307	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000138	0.000304	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000137	0.0003	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000135	0.000297	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000135	0.000296	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000135	0.000296	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000131	0.000288	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000131	0.000287	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000131	0.000287	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000129	0.000283	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000128	0.00028	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000125	0.000274	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000125	0.000274	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000125	0.000274	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000122	0.000267	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000121	0.000265	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000121	0.000265	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000118	0.000259	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000117	0.000258	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.000116	0.000255	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000115	0.000252	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000112	0.000245	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000111	0.000244	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000111	0.000244	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000111	0.000244	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.00011	0.000242	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00011	0.000241	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000109	0.00024	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000108	0.000238	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000108	0.000236	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000105	0.000231	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000104	0.000229	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000104	0.000228	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000104	0.000228	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000103	0.000225	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000102	0.000225	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000101	0.000222	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	9.97e-05	0.000219	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.91e-05	0.000218	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	9.9e-05	0.000218	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.89e-05	0.000217	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	9.84e-05	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.77e-05	0.000215	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	9.73e-05	0.000214	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	9.61e-05	0.000211	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	9.54e-05	0.00021	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	9.3e-05	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	9.17e-05	0.000201	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	9.15e-05	0.000201	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.07e-05	0.000199	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	9.05e-05	0.000199	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	8.93e-05	0.000196	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TH—polycystic ovary syndrome	8.87e-05	0.000195	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.82e-05	0.000194	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	8.63e-05	0.00019	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.55e-05	0.000188	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	8.42e-05	0.000185	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.41e-05	0.000185	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	8.11e-05	0.000178	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TH—polycystic ovary syndrome	7.92e-05	0.000174	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.73e-05	0.00017	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	7.7e-05	0.000169	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.67e-05	0.000169	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.52e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.5e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.28e-05	0.00016	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.26e-05	0.00016	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.24e-05	0.000159	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	7.24e-05	0.000159	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	7.09e-05	0.000156	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.07e-05	0.000155	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	6.9e-05	0.000152	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.68e-05	0.000147	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.66e-05	0.000146	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	6.54e-05	0.000144	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.47e-05	0.000142	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.47e-05	0.000142	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.31e-05	0.000139	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.24e-05	0.000137	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	6.16e-05	0.000135	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	6.1e-05	0.000134	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.01e-05	0.000132	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.99e-05	0.000132	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.95e-05	0.000131	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.92e-05	0.00013	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	5.84e-05	0.000128	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.7e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.66e-05	0.000124	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.59e-05	0.000123	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.5e-05	0.000121	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.44e-05	0.00012	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.37e-05	0.000118	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.31e-05	0.000117	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.01e-05	0.00011	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	4.94e-05	0.000109	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	4.88e-05	0.000107	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—polycystic ovary syndrome	4.85e-05	0.000107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.76e-05	0.000105	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.63e-05	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.41e-05	9.7e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.36e-05	9.57e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.35e-05	9.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.33e-05	9.51e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.31e-05	9.46e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.25e-05	9.33e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.23e-05	9.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.06e-05	8.92e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4e-05	8.8e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.98e-05	8.75e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.89e-05	8.54e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.7e-05	8.14e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.51e-05	7.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.27e-05	7.19e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.65e-05	5.83e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.62e-05	5.75e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.6e-05	5.72e-05	CbGpPWpGaD
